Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karuppaiyah Selvendiran
Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor
Oncoscience
Cancer Research
Oncology
Related publications
STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target
Journal of Cancer
Oncology
STAT3 Is Constitutively Activated and Supports Cell Survival in Association With Survivin Expression in Gastric Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701
Cancer Science
Cancer Research
Medicine
Oncology
A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo
Oncology Letters
Cancer Research
Oncology
Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Identification of BLCAP as a Novel STAT3 Interaction Partner in Bladder Cancer
PLoS ONE
Multidisciplinary
Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
A Sensible Approach to Targeting STAT3-mediated Transcription
Annals of Translational Medicine
Medicine
Selective FGFR Inhibitor BGJ398 Inhibits Phosphorylation of AKT and STAT3 and Induces Cytotoxicity in Sphere-Cultured Ovarian Cancer Cells
International Journal of Oncology
Cancer Research
Oncology